跳至主要内容
临床试验/NCT06110975
NCT06110975进行中(未招募)不适用

Deprescribing dRugs for Overactive Bladder in the Elderly in General Practice - a Randomized Controlled Trial With a Nested Mixed Methods Study

Anne Estrup Olesen2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
72
试验地点
2
主要终点
Difference in proportion of patients receiving drugs for overactive bladder

研究概览

简要总结

The objective is to understand and evaluate the effectiveness of a deprescribing intervention in primary care, specifically targeting medications for overactive bladder in individuals aged 65 or older.

详细描述

Potentially inappropriate medication is prescribed medications with an unfavorable risk-benefit profile, for which there might be better, safer, or more cost-effective alternatives. Anticholinergic drugs for Overactive Bladder (OAB) is an example of a potentially inappropriate medication in the elderly, calling for attention and possible deprescribing. Due to their crucial role in maintaining a patient's medication regimen, primary care settings are widely regarded as the optimal location for conducting medication reviews and deprescribing interventions.

This study utilizes a mixed methods explanatory sequential design, nested in a randomised controlled trial to explore deprescribing drugs for Overactive Bladder (OAB). General practices will be randomized into two groups. The intervention group will then be evaluated in a mixed methods setup and finish the study with a comparison to the control group. The mixed methods approach employs a quantitative approach following the intervention group and investigates the prevalence of deprescribing the drugs in question. Secondly, a qualitative approach will be used to delve into the experiences of general practitioners (GPs), support staff, and patients during the deprescribing process. Finally, the quantitative and qualitative findings are merged to gain a comprehensive understanding of deprescribing for OAB. This integrated approach enhances insights and informs future interventions and recommendations. After the mixed methods studies are completed the control group will be used in an overall comparison of the two groups using registry data

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
65 Years 至 95 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient must have been prescribed one of the following drugs for OAB within the last 14 months
  • patient must be able to speak and understand Danish

排除标准

  • too cognitively impaired to participate or otherwise unfit to participate as estimated by general practitioner
  • receiving neurological or urogenital ambulatory care for their overactive bladder symptoms

结局指标

主要结局

Difference in proportion of patients receiving drugs for overactive bladder

时间窗: 6 months

The primary outcome will be the difference in the proportion of patients receiving drugs for overactive bladder before and after a 6-month follow-up period.

次要结局

  • Changes and distribution of bladder symptoms(6 months)
  • The proportion of patients where deprescribing was not initiated(6 months)
  • proportion of patients in the intervention group who had deprescribing initiated but not sustained(6 months)

研究者

发起方
Anne Estrup Olesen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Anne Estrup Olesen

Professor

Aalborg University Hospital

研究点 (2)

Loading locations...

相似试验

Deprescribing dRrugs for Overactive Bladder in... | 临床试验